These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

107 related articles for article (PubMed ID: 6228930)

  • 1. [Directive principles for trials of cerebrally-acting drugs to be performed by groups of general practitioners].
    Hugonot L; Israël L; Hugonot R
    Presse Med; 1983 Dec; 12(48):3147-9. PubMed ID: 6228930
    [TBL] [Abstract][Full Text] [Related]  

  • 2. [Methodologic aspects in psychopharmacology].
    Kaumeier HS
    Methods Find Exp Clin Pharmacol; 1982; 4(7):539-42. PubMed ID: 6763118
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Does evidence from clinical trials in psychopharmacology apply in clinical practice?
    Stahl SM
    J Clin Psychiatry; 2001 Jan; 62(1):6-7. PubMed ID: 11235934
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Single case experiments in psychopharmacological trials.
    Wolfrum C; Klieser E; Lehmann E
    Neuropsychobiology; 1984; 12(2-3):152-7. PubMed ID: 6527757
    [TBL] [Abstract][Full Text] [Related]  

  • 5. [The clinical evaluation of psychopharmaceuticals in internal and general medicine. Elements for continuing psychopharmacologic and research education of the primary care physician].
    Castillo Pérez P
    An Med Interna; 1988 Sep; 5(9):471-81. PubMed ID: 2856628
    [No Abstract]   [Full Text] [Related]  

  • 6. [Voluntary description of drug effects as a method in clinical trials. Presented using the example of pentobarbital, promazine and their combination].
    Kohnen R; Lienert GA
    Arzneimittelforschung; 1979; 29(3):579-84. PubMed ID: 582749
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Developing methodologies for monitoring long-term safety of psychotropic medications in children: report on the NIMH conference, September 25, 2000.
    Greenhill LL; Vitiello B; Abikoff H; Levine J; March JS; Riddle MA; Capasso L; Cooper TB; Davies M; Fisher P; Findling RL; Fried J; Labellarte MJ; McCracken JT; McMahon D; Robinson J; Skrobala A; Scahill L; Varipatis E; Walkup JT; Zito JM
    J Am Acad Child Adolesc Psychiatry; 2003 Jun; 42(6):651-5. PubMed ID: 12921472
    [TBL] [Abstract][Full Text] [Related]  

  • 8. The private practice study group as phase-IV research tool.
    Helmchen H; Linden M; Schüssler G
    Pharmacopsychiatry; 1984 Sep; 17(5):157-61. PubMed ID: 6494245
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Challenges in psychopharmacology: a drug information centre perspective.
    Schjøtt J
    J Clin Pharm Ther; 2016 Feb; 41(1):4-6. PubMed ID: 26775691
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Why do clinical trials fail?
    Rickels K; Robinson DS
    J Clin Psychopharmacol; 2007 Aug; 27(4):420-1; author reply 421. PubMed ID: 17632242
    [No Abstract]   [Full Text] [Related]  

  • 11. Applied human psychopharmacology: the practical psychobiological consequences of some novel and ancient psychoactive drugs.
    Parrott AC; Murphy P; Scholey AB
    Hum Psychopharmacol; 2012 Mar; 27(2):103-5. PubMed ID: 22389074
    [No Abstract]   [Full Text] [Related]  

  • 12. Pharmaco-EEG experiments in animals.
    Stumpf C
    Neuropsychobiology; 1984; 12(2-3):179-82. PubMed ID: 6396529
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Contingent negative variation (CNV) in psychopharmacology.
    Timsit-Berthier M
    Electroencephalogr Clin Neurophysiol Suppl; 1991; 42():142-52. PubMed ID: 1915013
    [No Abstract]   [Full Text] [Related]  

  • 14. The application of the principles of clinical drug development to a pharmacological challenge test of the serotonergic system.
    Pinder RM
    J Psychopharmacol; 2004 Mar; 18(1):17; author reply 18-9. PubMed ID: 15107179
    [No Abstract]   [Full Text] [Related]  

  • 15. The uses of the intensive design in psychopharmacology.
    Kellner R; Rifkin A; Rada RI
    Psychopharmacol Bull; 1979 Jul; 15(3):35-7. PubMed ID: 493458
    [No Abstract]   [Full Text] [Related]  

  • 16. [Psychopharmacotherapy in the adult psychiatric domain].
    Bryois C
    Rev Med Suisse Romande; 2000 Feb; 120(2):123-9. PubMed ID: 10748698
    [No Abstract]   [Full Text] [Related]  

  • 17. [Method and device for evaluating the emotionally-positive effects of pharmacologic agents].
    Zvartau EE; Petriaevskaia NV; Gutkin NV; Kim VIu
    Zh Vyssh Nerv Deiat Im I P Pavlova; 1984; 34(4):802-3. PubMed ID: 6495867
    [No Abstract]   [Full Text] [Related]  

  • 18. [Pharmacology and child psychiatry].
    Simon P
    Psychiatr Enfant; 1978; 21(1):319-25. PubMed ID: 362457
    [No Abstract]   [Full Text] [Related]  

  • 19. Application of microarray technology in psychotropic drug trials.
    Murphy GM
    J Psychopharmacol; 2006 Jul; 20(4 Suppl):72-8. PubMed ID: 16785274
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Safety methodology in pediatric psychopharmacology trials.
    Yuill K; Carandang C
    J Child Adolesc Psychopharmacol; 2013 Apr; 23(3):148-62. PubMed ID: 23607408
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.